<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="159952">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02157194</url>
  </required_header>
  <id_info>
    <org_study_id>RLK-EBUS-2</org_study_id>
    <secondary_id>11-4921-BO</secondary_id>
    <nct_id>NCT02157194</nct_id>
  </id_info>
  <brief_title>Endobronchial Ultrasound-transbronchial Needle Aspiration (EBUS-TBNA) Sample Division</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Essen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Essen</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      EBUS-TBNA specimen are used for lung cancer diagnosing and staging, as well for molecular
      analysis. The purpose of this study is to evaluate if samples from on lymph node site can be
      divided for diagnosis and molecular analysis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Sensitivity and Specificity of lung cancer diagnosis</measure>
    <time_frame>6 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>We aim to evaluate if splitting the obtained specimen will have an impact on lung cancer diagnosis performed by histopathologic analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of successful performed molecular RNA based analysis</measure>
    <time_frame>3 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will analyse the second half of the sample regarding molecular analysis. RNA concentration and RNA integrity score will be assessed before a new RNA based test will be evaluated.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <condition>Lung Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects suspected to have lung cancer and enlarged mediastinal lymph nodes
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical diagnosis of lung cancer

          -  enlarged mediastinal or hilar lymph nodes (&gt;10 mm)

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Kaid Darwiche, MD</last_name>
    <phone>+49201433 ext 4219</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Ruhrlandklinik-UK Essen</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaid Darwiche, MD</last_name>
    </contact>
    <investigator>
      <last_name>Kaid Darwiche, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <lastchanged_date>June 3, 2014</lastchanged_date>
  <firstreceived_date>June 1, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Essen</investigator_affiliation>
    <investigator_full_name>Kaid Darwiche</investigator_full_name>
    <investigator_title>Senior Physician Interventional Pneumology</investigator_title>
  </responsible_party>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
